1. LaFranchi S. Hypoglycemia of infancy and childhood. Pediatr Clin North Am. 1987; 34:961–82.
Article
2. Daly LP, Osterhoudt KC, Weinzimer SA. Presenting features of idiopathic ketotic hypoglycemia. J Emerg Med. 2003; 25:39–43.
Article
3. Colle E, Ulstrom RA. Ketotic hypoglycemia. J Pediatr. 1964; 64:632–51.
Article
4. Pershad J, Monroe K, Atchison J. Childhood hypoglycemia in an urban emergency department: epidemiology and a diagnostic approach to the problem. Pediatr Emerg Care. 1998; 14:268–71.
5. Drachmann D, Hoffmann E, Carrigg A, Davis-Yates B, Weaver V, Thornton P, et al. Towards enhanced understanding of idiopathic ketotic hypoglycemia: a literature review and introduction of the patient organization, Ketotic Hypoglycemia International. Orphanet J Rare Dis. 2021; 16:173.
Article
6. López-Ojeda W, Hurley RA. Ketone Bodies and brain metabolism: new insights and perspectives for neurological diseases. J Neuropsychiatry Clin Neurosci. 2023; 35:104–9.
Article
7. Brown LM, Corrado MM, van der Ende RM, Derks TG, Chen MA, Siegel S, et al. Evaluation of glycogen storage disease as a cause of ketotic hypoglycemiain children. J Inherit Metab Dis. 2015; 38:489–93.
8. Azcona C, Stanhope R. Hypoglycaemia and Russell-Silver syndrome. J Pediatr Endocrinol Metab. 2005; 18:663–70.
Article
9. White K, Truong L, Aaron K, Mushtaq N, Thornton PS. The incidence and etiology of previously undiagnosed hypoglycemic disorders in the emergency department. Pediatr Emerg Care. 2020; 36:322–6.
Article
10. Murphy A, Raftery J. Ketotic hypoglycemia. Ir Med J. 1975; 68:586–8.
11. Benner A, Alhaidan Y, Lines MA, Brusgaard K, De Leon DD, Sparkes R, et al. PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only. Am J Med Genet A. 2021; 185:2959–75.
12. Monde AA, Djessou SP, Camara CM, Tiahou GG, Koffi G, Djohan F, et al. Prevalence of ketotic hypoglycemia among school children in the village of Ahoue in Cote-d'Ivoire. Bull Soc Pathol Exot. 2010; 103:96–9.
13. White NJ, Miller KD, Marsh K, Berry CD, Turner RC, Williamson DH, et al. Hypoglycaemia in African children with severe malaria. Lancet. 1987; 1:708–11.
Article
14. Drachmann D, Carrigg A, Weinstein DA, Petersen JS, Christesen HT. Ketotic hypoglycemia in patients with Down syndrome. JIMD Rep. 2021; 62:70–3.
Article
15. Kaplowitz P, Sekizkardes H. Clinical and laboratory characteristics and follow up of 62 cases of ketotic hypoglycemia: a retrospective study. Int J Pediatr Endocrinol. 2019; 2019:3.
Article
16. Gandhi K. Approach to hypoglycemia in infants and children. Transl Pediatr. 2017; 6:408–20.
Article
17. Grunt JA, Howard RO. Findings in children with ketotic hypoglycemia. Can J Ophthalmol. 1972; 7:151–6.
18. Wets B, Milot JA, Polomeno RC, Letarte J. Cataracts and ketotic hypoglycemia. Ophthalmology. 1982; 89:999–1002.
Article
19. Mridha MA, Matin A. Ketotic hypoglycemia in children: a review. Banglad J Child Health. 2019; 43:113–6.
Article
20. Millar R, Harding A. Review article: accelerated starvation of childhood: Have I judged ketones? Emerg Med Australas. 2019; 31:314–20.
Article
21. Woo HC, Tolosa L, El-Metwally D, Viscardi RM. Glucose monitoring in neonates: need for accurate and non-invasive methods. Arch Dis Child Fetal Neonatal Ed. 2014; 99:F153–7.
Article
22. Vanelli M, Mastrorilli C, Fainardi V, Iovane B, Scarabello C, Veronese P, et al. Clinical utility of beta-hydroxybutyrate measurement in the management of physiological ketosis at home in children under 5. Acta Biomed. 2019; 90:215–20.
23. Matthieu JM, Boulat O. L'hypoglycémie cétotique de l'enfant [Ketotic hypoglycemia in children]. Rev Med Suisse Romande. 2002; 122:640–4. French.
24. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009; 94:709–28.
Article
25. Ross KM, Brown LM, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, et al. Safety and efficacy of chronic extended release cornstarch therapy for glycogen storage disease type I. JIMD Rep. 2016; 26:85–90.
Article